Accordingly, plasma IL-18 level was also significantly elevated in newly-diagnosed lymphoma patients than in controls (p < 0.0001, Figure 2D), and decreased after chemotherapy remission in the paired 11 patients (p = 0.0098, Figure 2E). This evidence concerns the gene IL18 and lymphoma.